1. Pink Sheet
  2. >>Compliance
  3. >>Manufacturing

FDA Urges Full Participation In Quality Metrics Program

 
• By Joanne S. Eglovitch

Despite the voluntary nature of US FDA’s program, an agency official urges full participation. Without data from such participation, FDA will not be able to predict drug shortages and industry will not see the benefits of reduced inspections and streamlined change control.

Pharmaceutical companies should participate in FDA’s quality metrics program and submit metrics data once an electronic portal goes live Jan. 1, 2018, Ashley Boam, acting director for the FDA’s Office of Policy for Pharmaceutical Quality, said Feb. 22 at the Parenteral Drug Association’s meeting on quality metrics and quality culture in Bethesda Md.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Manufacturing

More from Compliance